It is projected that the global liquid biopsy industry would generate US$ 1,538.3 million in revenue by 2023. According to our healthcare domain specialists, liquid biopsy providers should anticipate strong growth, with a projected revenue of US$ 10,938.6 million by 2033 and a CAGR of 21.7% through that year. One of the key factors driving …
Continue reading “Liquid Biopsy Industry Set to Surge Beyond US$ 4,126 Million by 2032-FMI Report”